Sort   by:  
 Page size 
MetabolomicsP. falciparum infected erythrocytes
Not available
ORGANISM(S): Plasmodium falciparum 
ST001188 | MetabolomicsWorkbench
MetabolomicsAnalysis of sex-specific lipid metabolism of Plasmodium falciparum points to the importance of sphingomyelin for gametocytogenesis
Male and female Plasmodium falciparum gametocytes are the parasite lifecycle stage responsible for transmission of malaria from the human host to the mosquito vector. Not only are gametocytes able to survive in radically different host environments, but they are also precursors for male and female g...
2022-04-05 | MTBLS4137 | MetaboLights
MetabolomicsMetabolic balancing by miR-276 shapes the mosquito reproductive cycle and Plasmodium falciparum development
The blood-feeding behavior of Anopheles females delivers essential nutrients for egg development and drives parasite transmission between humans. Plasmodium growth is adapted to the vector reproductive cycle, but how changes in the reproductive cycle impact parasite development remains unclear. Here...
2021-11-03 | MTBLS1282 | MetaboLights
MetabolomicsMechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum

The emergence of multi-drug resistant Plasmodium falciparum underscores the urgent need for new antimalarial therapies. SC83288, a novel chemical entity, is highly effective against P. falciparum both in vivo and in vitro, including strains resistant to artemisinin and partner drugs. Here, we sho...

2026-02-16 | MTBLS13911 | MetaboLights
MetabolomicsPeroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites
Not available
ORGANISM(S): Plasmodium falciparum;Homo sapiens 
ST001202 | MetabolomicsWorkbench
MetabolomicsPeroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites
Not available
ORGANISM(S): Plasmodium falciparum;Homo sapiens 
ST001201 | MetabolomicsWorkbench
TranscriptomicsStructural polymorphism in the promoter of pfmrp2 confers tolerance to mefloquine and chloroquine in Plasmodium falciparum [CGH]
Drug resistance in Plasmodium falciparum remains a challenge for the malaria eradication programs around the world. With the emergence of artemisinin resistance, the efficacy of the partner drugs in the artemisinin combination therapies (ACT) that include quinoline based drugs is becoming critical. ...
ORGANISM(S): Plasmodium falciparum 
2013-02-07 | E-GEOD-44128 | biostudies-arrayexpress
MetabolomicsPeroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites
Not available
ORGANISM(S): Plasmodium falciparum;Homo sapiens 
ST001204 | MetabolomicsWorkbench
TranscriptomicsStructural polymorphism in the promoter of pfmrp2 confers tolerance to mefloquine and chloroquine in Plasmodium falciparum [expression]
Drug resistance in Plasmodium falciparum remains a challenge for the malaria eradication programs around the world. With the emergence of artemisinin resistance, the efficacy of the partner drugs in the artemisinin combination therapies (ACT) that include quinoline based drugs is becoming critical. ...
ORGANISM(S): Plasmodium falciparum 
2013-02-07 | E-GEOD-44127 | biostudies-arrayexpress
MetabolomicsPeroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites
Not available
ORGANISM(S): Plasmodium falciparum;Homo sapiens 
ST001205 | MetabolomicsWorkbench
Sort   by:  
 Page size